Chemcrux Enterprises Ltd
Incorporated in 1996, Chemcrux Enterprises Ltd manufactures and processes bulk drug intermediates[1]
- Market Cap ₹ 177 Cr.
- Current Price ₹ 119
- High / Low ₹ 230 / 100
- Stock P/E 63.8
- Book Value ₹ 50.4
- Dividend Yield 0.84 %
- ROCE 6.69 %
- ROE 5.05 %
- Face Value ₹ 10.0
Pros
- Company has been maintaining a healthy dividend payout of 25.4%
- Company's working capital requirements have reduced from 50.2 days to 27.9 days
Cons
- Company has a low return on equity of 12.8% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|
95.27 | 95.15 | 78.47 | 70.01 | 69.40 | |
74.56 | 73.69 | 65.10 | 60.78 | 60.61 | |
Operating Profit | 20.71 | 21.46 | 13.37 | 9.23 | 8.79 |
OPM % | 21.74% | 22.55% | 17.04% | 13.18% | 12.67% |
1.00 | 1.05 | 1.18 | 1.49 | 1.55 | |
Interest | 0.17 | 0.82 | 0.83 | 1.75 | 2.48 |
Depreciation | 1.59 | 2.04 | 2.29 | 3.21 | 3.82 |
Profit before tax | 19.95 | 19.65 | 11.43 | 5.76 | 4.04 |
Tax % | 25.51% | 26.92% | 26.16% | 32.12% | |
14.86 | 14.36 | 8.44 | 3.91 | 2.77 | |
EPS in Rs | 10.03 | 9.70 | 5.70 | 2.64 | 1.87 |
Dividend Payout % | 19.93% | 20.63% | 17.55% | 37.88% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -10% |
TTM: | -5% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -37% |
TTM: | -62% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 14% |
3 Years: | -35% |
1 Year: | -43% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 13% |
Last Year: | 5% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
Equity Capital | 14.81 | 14.81 | 14.81 | 14.81 |
Reserves | 39.87 | 51.60 | 57.45 | 59.81 |
9.75 | 14.43 | 26.46 | 42.30 | |
19.34 | 12.38 | 11.15 | 10.13 | |
Total Liabilities | 83.77 | 93.22 | 109.87 | 127.05 |
25.49 | 33.11 | 33.09 | 77.06 | |
CWIP | 0.00 | 0.31 | 21.06 | 1.61 |
Investments | 7.08 | 16.79 | 19.83 | 19.83 |
51.20 | 43.01 | 35.89 | 28.55 | |
Total Assets | 83.77 | 93.22 | 109.87 | 127.05 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
9.16 | 14.82 | 16.34 | 7.59 | |
-2.64 | -20.48 | -25.89 | -2.48 | |
3.96 | 0.96 | 7.64 | -9.16 | |
Net Cash Flow | 10.49 | -4.70 | -1.91 | -4.04 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
Debtor Days | 72.33 | 51.56 | 71.17 | 61.42 |
Inventory Days | 92.33 | 124.92 | 99.63 | 135.16 |
Days Payable | 92.57 | 71.19 | 70.84 | 60.56 |
Cash Conversion Cycle | 72.09 | 105.28 | 99.96 | 136.01 |
Working Capital Days | 37.43 | 67.28 | 55.49 | 27.94 |
ROCE % | 27.63% | 13.46% | 6.69% |
Documents
Announcements
-
Communication For TDS On Dividend For F.Y. 2024-25
30 Aug - Final dividend Re.1/share; AGM 24 Sep 2025; record date 17 Sep 2025; TDS rules, documents due 17 Sep 2025.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 30 Aug
-
Regulation 36(1)(B) Of SEBI Listing Regulations - Letter To Shareholders Containing The Web-Link Of The Annual Report And AGM Notice
30 Aug - Web-links of Chemcrux 2024-25 Annual Report and AGM notice; AGM on 24 Sep 2025 via VC/OAVM.
- Record Date For Final Dividend To Be Declared At 29Th AGM 29 Aug
-
Book Closure Dates And E-Voting Schedule For 29Th AGM
29 Aug - CHEMCRUX: AGM on 24 Sep 2025; book closure 18–24 Sep; e-voting 21–23 Sep; record date 17 Sep.
Business Overview:[1]
CEL is an ISO 9001:2015, ISO 14001:2015 and ISO 50001:2018 certified company. It specializes in High Pressure Oxidation, Nitration, Chlorosulfonation and Amidation Chemistry - manufacturing intermediates
for bulk drugs(API), dyes & pigment, electro-plating, pharmaceuticals, dyes and pigments industries